Not theoretical filings. Each patent represents a real solved problem — a specific technical barrier overcome at bench level and validated by international patent bodies.
WIPO Gold Medal 2018 confirms the quality of this body of work. All patents co-held with Dr. Nicholas Khong Mun Hoe, filed under MyIPO Malaysia with international coverage.
A selection from the portfolio — each patent representing a real technical barrier overcome, not a speculative filing.
Encapsulating lipophilic antioxidants from red palm olein into flour-based dough without compromising taste, texture, or shelf life. Enables everyday foods with proven health benefits — bringing bioactive ingredients to mass-market food formats.
Natural antioxidant and antimicrobial composition derived from palm oil — a science-backed alternative to synthetic preservatives for food, cosmetics, and pharmaceutical applications. Clean-label compliant.
Edible or topical film with sustained antimicrobial and antioxidant release. Applications span active food packaging, medicated wound dressings, and cosmetic sheet masks — a single IP covering three distinct commercial sectors.
Efficient extraction of water-soluble polyphenols from oil palm leaves — turning agricultural waste into high-value ingredients for health teas and natural antioxidant applications. Circular economy at bench level.
Nanoemulsion therapeutic composition using nanonized vitamins from oil palm — enhancing skin penetration, stability, and efficacy for treating skin conditions. The science behind the skincare products distributed across 200+ pharmacies.
Microencapsulation method creating an oil-in-water emulsion that masks the taste and colour of red palm olein while dramatically improving stability and lipophilic nutrient bioavailability — enabling palm bioactives to reach mainstream food and supplement formats.
Every patent in this portfolio was co-invented with Dr. Nicholas Khong Mun Hoe — a collaboration that spans over a decade of bench work, testing, and iterative development across food science, cosmetics, and bioactive delivery systems.
The patents represent not just intellectual property filings — they represent real problems solved at scale, validated by three international award bodies, and applied in products that have reached commercial distribution.
What this portfolio means in practice — for clients who want a product that competitors cannot simply copy at half the price.
The techniques behind these patents — microencapsulation, nanoemulsification, bioactive delivery — are applied directly in client products. You are not getting a theory; you are getting proven bench-level science.
When a product is built on patent-grade science, the claims that support its marketing are evidence-backed and defensible — not marketing language that competitors can match with a factory reformulation.
Products with genuine IP behind them command price premiums that factory-formula competitors cannot match without access to the same science. That is the difference between a moat and a margin squeeze.